Concepedia

Glenn S. Tillotson

GS

Statistics

Publications

11

Citations

513

H-Index

11

Active since

1988

Affiliations

McMaster University(Current)

Human BioMolecular Research Institute

Summa Health System

Teledyne Technologies (United States)

Glenn S. Tillotson is an author at McMaster University specializing in medicine, antimicrobial resistance, and clinical microbiology.

ORCID

Top concepts

Publications per year

1988–2017

11

Publications

11

Safety of Fluoroquinolones: An Update

Lionell Mandell, Glenn S. Tillotson · Canadian Journal of Infectious Diseases and Medical Microbiology · 2002 · 126 citations · Full text

, , +18

National and Regional Assessment of Antimicrobial Resistance among Community-Acquired Respiratory Tract Pathogens Identified in a 2005-2006 U.S. Faropenem Surveillance Study

Ian A. Critchley, Steven D. Brown, Maria M. Traczewski et al. · Antimicrobial Agents and Chemotherapy · 2007 · 71 citations · Full text

, , +16

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study

Thomas M. File, Lionel A. Mandell, Glenn S. Tillotson et al. · Journal of Antimicrobial Chemotherapy · 2007 · 66 citations

Introduction: Sepsis

Glenn S. Tillotson · CHEST Journal · 2009 · 60 citations

Chemotherapy for chronic bronchitis. Controversies.

Peter Ball, Glenn S. Tillotson, R Wilson · PubMed · 1995 · 42 citations

1–5 of 11